Launching a cosmetic product in Japan

An overseas brand wants to sell a finished cosmetic product in Japan. Even if packaging and manufacturing are complete abroad, a business in Japan must take responsibility for releasing the product to the market and ensuring its quality and safety.

This guide concerns ordinary cosmetics imported for conventional retail sale. Requirements depend on the actual product, its claims and the sales arrangement; products in another regulatory category need a separate review. Sources were checked on 3 November 2026. For the wider comparison, see launching cosmetics across markets.

This article was generated with AI and checked against the sources linked below. It has not been independently reviewed by a local regulatory professional.

Check the product’s classification

Japan’s framework distinguishes cosmetics from drugs and quasi-drugs. A change in formula, purpose or claims can change the applicable route. Review the final product name, formula, directions, advertising and intended effects together. Do not assume a classification granted in another country carries over.

The discussion below concerns the ordinary cosmetic route. Products needing individual approval or falling under another category require separate examination. Clarify the route with the Japanese partner before promising a launch date.

Identify the market-release business

The business that markets cosmetics in Japan needs the applicable cosmetics marketing licence. The marketing business has quality and safety responsibilities. The licence is a business permission, not a product-specific approval. Japan’s Ministry of Justice provides an English translation of the Pharmaceuticals and Medical Devices Act, Articles 12 and 12-2. That translation reflects amendments through 2015; confirm later changes and applicable subordinate rules for a launch.

The Act also addresses manufacturing licences separately. Identify the businesses that manufacture, import, label and store the product, and check which licences and procedures apply to the planned arrangement. A business may use a separate manufacturer, but that does not remove the marketing business’s own obligations.

Confirm the legal entities and facilities, who controls each licence and who will decide whether each batch can be released. Follow the applicable prefectural and national procedures for the actual arrangements.

What the marketing business is responsible for

The marketing business needs to address applicable quality control and post-marketing safety requirements. Agree how it will receive manufacturing and batch information, assess quality complaints and coordinate a response to a potential defect. The English translation of Japan’s Act describes quality-control and post-marketing safety standards for marketing licences. Japan Ministry of Justice: Act, Articles 12-2 and 68-9.

Set up routes for manufacturing records, consumer enquiries, safety information and decisions before the first release. The overseas brand should agree who supplies evidence and supports an investigation; a contract cannot transfer the licence holder’s statutory duties away from it. The Act’s English translation also describes recall-reporting duties, subject to the applicable procedures and exceptions.

What happens if requirements are breached?

The English translation of Japan’s pharmaceuticals legislation describes possible measures including orders to improve quality or safety controls, suspension of operations and licence revocation in specified circumstances. The outcome depends on the conduct and the legal provisions applied; a quality complaint by itself does not establish a breach or an automatic penalty. Civil claims and contractual cost allocation raise separate questions. Check the current law and procedure for an actual incident. Japan Ministry of Justice: Act, Articles 72 and 75.

Plan the product and import procedures

PMDA says an application for marketing approval is not necessary to sell cosmetics, but the product must comply with the Standards for Cosmetics. This does not mean that a business licence or other applicable procedures can be skipped. Products classified as quasi-drugs or medicines follow different routes. PMDA: cosmetics FAQ.

Before shipment, ask the licensed Japanese business to confirm the applicable product and foreign-manufacturer notifications, import documentation and timing for the arrangement. Keep the product procedure separate from the business licence and customs clearance.

Check ingredients, safety and the label

Compare the full formula and concentrations with Japan’s current Standards for Cosmetics, including prohibited and restricted ingredients and the conditions for substances in regulated categories. Ask suppliers for the composition of blends and fragrances where needed. A trade name or an overseas-compliant label alone may not give the Japanese partner enough information for the check.

Prepare product-specific quality information and assess the evidence needed to support safety under the intended conditions of use. Record the formulation, manufacturer, specifications and proposed Japanese label together so the release decision relates to the correct product.

Japanese requirements address details such as the product name, manufacturing and marketing business, batch identification and ingredient disclosure, subject to the applicable rules and exceptions. Review the final Japanese-language presentation and placement of information with the responsible business. The label must not mislead consumers about the product or its effects.

Keep control after launch

Agree how the Japanese marketing business receives complaints, investigates quality issues and coordinates withdrawals or recalls with the overseas manufacturer. Keep supplier specifications, batch release information and current labels accessible to the people who need them.

A new fragrance supplier, a reformulation or a claim change can affect the ingredient review, product notification or label. Before implementing a change, identify what must be updated and which batches and markets it affects.

Sources

• PMDA: frequently asked questions, Q12-2 on cosmetics.
• Japan Ministry of Justice: English translation of the Pharmaceuticals and Medical Devices Act. This translation is an older version, amended through 2015; check later amendments and applicable subordinate rules for a particular launch.